Central Executive Training and Parent Training for ADHD

NCT ID: NCT05492422

Last Updated: 2025-03-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-03

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the current project is to combine two evidence- based treatments for school-aged children with ADHD: Central Executive Training (CET) and Behavioral Parent Training (BPT). CET is a computerized training intervention that improves ADHD symptoms and academic functioning by improving children's working memory abilities. BPT is a therapeutic intervention that improves family functioning and child oppositional-defiant (ODD) symptoms by changing parenting behaviors. Their combined use is expected to provide complementary and additive benefits, particularly if CET is delivered before BPT.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ADHD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CET-then-BPT

Families receive CET in Phase 1 followed by BPT in Phase 2

Group Type EXPERIMENTAL

Central Executive Training (CET)

Intervention Type DEVICE

Central Executive Training (CET)

Behavioral Parent Training (BPT)

Intervention Type BEHAVIORAL

Behavioral Parent Training (BPT)

BPT-then-CET

Families receive BPT in Phase 1 followed by CET in Phase 2

Group Type EXPERIMENTAL

Central Executive Training (CET)

Intervention Type DEVICE

Central Executive Training (CET)

Behavioral Parent Training (BPT)

Intervention Type BEHAVIORAL

Behavioral Parent Training (BPT)

Waitlist then CET+BPT

Families do not receive either intervention in Phase 1 and then receive both CET and BPT concurrently in Phase 2

Group Type EXPERIMENTAL

Central Executive Training (CET)

Intervention Type DEVICE

Central Executive Training (CET)

Behavioral Parent Training (BPT)

Intervention Type BEHAVIORAL

Behavioral Parent Training (BPT)

CET+BPT then 'waitlist' (follow-up)

Families receive CET and BPT concurrently in Phase 1, and then are followed in Phase 2 with not additional intervention

Group Type EXPERIMENTAL

Central Executive Training (CET)

Intervention Type DEVICE

Central Executive Training (CET)

Behavioral Parent Training (BPT)

Intervention Type BEHAVIORAL

Behavioral Parent Training (BPT)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Central Executive Training (CET)

Central Executive Training (CET)

Intervention Type DEVICE

Behavioral Parent Training (BPT)

Behavioral Parent Training (BPT)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Children ages 8-12 with principal ADHD diagnoses (via K-SADS); and
2. parent AND teacher ratings in clinical/borderline range based on age and sex on ADHD Rating Scale (ADHD-5) or Behavior Assessment Scale for Children (BASC-3) Attention Problems/Hyperactivity subscales (i.e., 90th percentile or higher based on both informants).

All DSM-5 ADHD presentations will be eligible.

Exclusion:

1. gross neurological, sensory, or motor impairment;
2. history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with participation (e.g., disruptive mood dysregulation, intermittent explosive, reactive attachment, substance use);
3. intellectual disability or Wechsler Intelligence Scale for Children (WISC-V) short-form standard score \<70;
4. conditions requiring acute intervention, e.g., active suicidality; and
5. non-English speaking child or parent.
Minimum Eligible Age

8 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Florida State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michael J. Kofler

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Florida State University

Tallahassee, Florida, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Children's Learning Clinic

Role: CONTACT

8506457423

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Children's Learning Clinic

Role: primary

850-645-7423

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01MH125893

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.